Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Terminated × Asthma × Clear all

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 2 1

Status

Completed 11 Unknown 4 Recruiting 2 Enrolling by invitation 2 Withdrawn 1 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 158 Neoplasms 131 Prostatic Neoplasms 89 Lung Neoplasms 72 Colorectal Neoplasms 49 Carcinoma, Non-Small-Cell Lung 49 Pancreatic Neoplasms 42 Head and Neck Neoplasms 39 Rectal Neoplasms 36 Multiple Myeloma 36 Carcinoma, Hepatocellular 36 Brain Neoplasms 33 Colonic Neoplasms 30 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Esophageal Neoplasms 29 Leukemia 28 Neoplasm Metastasis 27 Lymphoma, Non-Hodgkin 27 Leukemia, Myeloid, Acute 27 Lymphoma 25 Ovarian Neoplasms 24 Uterine Cervical Neoplasms 23 Motor Activity 23 Hodgkin Disease 23 Pain 19 Carcinoma, Renal Cell 19 Leukemia, Lymphocytic, Chronic, B-Cell 18 Glioma 18 Anxiety Disorders 18 Lymphoma, Follicular 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02872298 2022-04-12

RELIEF-1

Nuvaira, Inc.

Phase NA Terminated

Asthma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡